Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Girard

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
Clinical Biochemistry|April 29, 2008
Advantages of prostate-specific antigen (PSA) clearance model over simple PSA half-life computation to describe PSA decrease after prostate adenomectomyBenoit You, Paul Perrin, Gilles Freyer, et al.
European Journal of Cancer (Oxford, England : 1990)|January 31, 2012
Predictors of prescription errors involving anticancer chemotherapy agentsFlorence Ranchon, Céline Moch, Benoît You, et al.
CPT: Pharmacometrics & Systems Pharmacology|April 14, 2019
Time-Varying Clearance and Impact of Disease State on the Pharmacokinetics of Avelumab in Merkel Cell Carcinoma and Urothelial CarcinomaJustin J Wilkins, Brigitte Brockhaus, Haiqing Dai, et al.
Lung Cancer (Amsterdam, Netherlands)|April 30, 2008
Etoposide pharmacokinetics and survival in patients with small cell lung cancer: a multicentre studyBenoit You, Brigitte Tranchand, Pascal Girard, et al.
BMC Research Notes|July 5, 2015
Adherence to oral anticancer chemotherapy: What influences patients' over or non-adherence? Analysis of the OCTO study through quantitative-qualitative methodsAurélie Bourmaud, Emilie Henin, Fabien Tinquaut, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 9, 2022
Disease trajectory of SLE clinical endpoints and covariates affecting disease severity and probability of response: Analysis of pooled patient-level placebo (Standard-of-Care) data to enable model-informed drug developmentKosalaram Goteti, Jonathan French, Ramon Garcia, et al.
Cancer Chemotherapy and Pharmacology|June 28, 2018
Over-adherence to capecitabine: a potential safety issue in breast and colorectal cancer patientsOlivia Le Saux, Aurélie Bourmaud, Catherine Rioufol, et al.
JCO Clinical Cancer Informatics|May 5, 2023
Semiautomated Pipeline to Quantify Tumor Evolution From Real-World Positron Emission Tomography/Computed Tomography ImagingDaniel Abler, Perrine Courlet, Matthieu Dietz, et al.
Studies in Health Technology and Informatics|June 15, 2010
Grid-wide neuroimaging data federation in the context of the NeuroLOG projectFranck Michel, Alban Gaignard, Farooq Ahmad, et al.
Medical Image Analysis|December 22, 2017
The first MICCAI challenge on PET tumor segmentationMathieu Hatt, Baptiste Laurent, Anouar Ouahabi, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Clinical Biochemistry|April 29, 2008
Advantages of prostate-specific antigen (PSA) clearance model over simple PSA half-life computation to describe PSA decrease after prostate adenomectomyBenoit You, Paul Perrin, Gilles Freyer, et al.
European Journal of Cancer (Oxford, England : 1990)|January 31, 2012
Predictors of prescription errors involving anticancer chemotherapy agentsFlorence Ranchon, Céline Moch, Benoît You, et al.
CPT: Pharmacometrics & Systems Pharmacology|April 14, 2019
Time-Varying Clearance and Impact of Disease State on the Pharmacokinetics of Avelumab in Merkel Cell Carcinoma and Urothelial CarcinomaJustin J Wilkins, Brigitte Brockhaus, Haiqing Dai, et al.
Lung Cancer (Amsterdam, Netherlands)|April 30, 2008
Etoposide pharmacokinetics and survival in patients with small cell lung cancer: a multicentre studyBenoit You, Brigitte Tranchand, Pascal Girard, et al.
BMC Research Notes|July 5, 2015
Adherence to oral anticancer chemotherapy: What influences patients' over or non-adherence? Analysis of the OCTO study through quantitative-qualitative methodsAurélie Bourmaud, Emilie Henin, Fabien Tinquaut, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 9, 2022
Disease trajectory of SLE clinical endpoints and covariates affecting disease severity and probability of response: Analysis of pooled patient-level placebo (Standard-of-Care) data to enable model-informed drug developmentKosalaram Goteti, Jonathan French, Ramon Garcia, et al.
Cancer Chemotherapy and Pharmacology|June 28, 2018
Over-adherence to capecitabine: a potential safety issue in breast and colorectal cancer patientsOlivia Le Saux, Aurélie Bourmaud, Catherine Rioufol, et al.
JCO Clinical Cancer Informatics|May 5, 2023
Semiautomated Pipeline to Quantify Tumor Evolution From Real-World Positron Emission Tomography/Computed Tomography ImagingDaniel Abler, Perrine Courlet, Matthieu Dietz, et al.
Studies in Health Technology and Informatics|June 15, 2010
Grid-wide neuroimaging data federation in the context of the NeuroLOG projectFranck Michel, Alban Gaignard, Farooq Ahmad, et al.
Medical Image Analysis|December 22, 2017
The first MICCAI challenge on PET tumor segmentationMathieu Hatt, Baptiste Laurent, Anouar Ouahabi, et al.
Pageof 8